The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,220.00
Bid: 1,214.00
Ask: 1,220.00
Change: 2.00 (0.16%)
Spread: 6.00 (0.494%)
Open: 1,204.00
High: 1,220.00
Low: 1,204.00
Prev. Close: 1,218.00
KNOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kainos Acquires Formulate and Implexa

11 Nov 2019 07:01

RNS Number : 8720S
Kainos Group plc
11 November 2019
 

RNS REACH

11 November 2019

Kainos Group plc

 

("Kainos" or the "Company")

 

Kainos Acquires Formulate and Implexa

 

Kainos (LSE: KNOS), a leading UK-based provider of digital services and platforms, is pleased to announce today further investment into Adaptive Insights' UK and European markets through the acquisitions of Formulate (Adaptive) Limited ("Formulate"), and the Adaptive Insights arm of Implexa GmbH ("Implexa").

 

Formulate is a leading UK and European partner to Adaptive Insights: a financial and business planning software business which is part of Workday, Inc. Established in 2016 and headquartered in Worcestershire in the UK, Formulate is one of the leading European partners to Adaptive Insights. Formulate supports customers in implementing Adaptive Insight's software; building and refining forecasting solutions. Formulate's team of 16 combines both software and consulting capabilities, and provides its services to more than 100 customers across the UK and Europe.

 

Implexa is the only accredited Adaptive Insights partner in Germany, and adds Hamburg-based software and consulting capabilities to Kainos' existing Frankfurt presence and capabilities.

 

Both acquisitions help Kainos to build and expand on its Workday offering, and to grow its presence in key markets. By acquiring both businesses, Kainos strengthens its capabilities to sell, deliver and support Adaptive Insights financial planning customer success across the UK and wider Europe.

 

The terms of the investments have not been disclosed.

 

Commenting on the acquisition Brendan Mooney, CEO, Kainos, said:

 

"I am delighted to welcome the Formulate and Implexa teams to Kainos. The quality and unique expertise of the teams, paired with their complementary values, were integral in our decision to make these acquisitions.

 

We continue to see growing demand from organisations across the UK and Europe in modernising employee experience and financial management systems. By partnering with Workday, and as it continues to expand its products, we'll be able to enhance our value to customers."

 

For further information, please contact:

 

Kainos Group plc via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Kwaku Aning / Leah Dudley

 

 

About Kainos

Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

 

The Group's Digital Platforms comprise specialised digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for the digitisation of patient notes in the Acute sector of the NHS.

 

Kainos has over 1,550 people across 12 offices in Europe and North America.

 

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com 

 

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFSLFWAFUSEFF
Date   Source Headline
4th Sep 20177:00 amRNSTrading Update
17th Aug 20174:32 pmRNSHolding(s) in Company
31st Jul 20173:08 pmRNSAnnual Report 2017 and Notice of AGM
11th Jul 201711:01 amRNSDirector/PDMR shareholdings
6th Jul 20177:00 amRNSFirst Irish customer for Kainos Evolve
3rd Jul 20174:29 pmRNSDirector/PDMR Shareholding
29th Jun 201712:33 pmRNSHolding(s) in Company
30th May 20177:00 amRNSPreliminary Results
12th Apr 20177:00 amRNSTrading Update
27th Mar 201712:01 pmRNSHolding(s) in Company
6th Mar 201710:00 amRNSKainos expands its Workday services in Europe
28th Nov 20167:00 amRNSInterim Results
14th Nov 20167:00 amRNSAppointment of Joint Corporate Broker
2nd Nov 20167:00 amRNSNotice of Results
22nd Sep 20161:45 pmRNSResult of AGM
6th Sep 20167:00 amRNSTrading Update
29th Jul 20165:00 pmRNSAnnual Report 2016 and Notice of AGM
21st Jul 20165:47 pmRNSAward of Shares under SIP and Directors' Dealings
30th Jun 20165:10 pmRNS2016 LTIP Awards - Replacement
30th Jun 20164:25 pmRNS2016 LTIP Awards
13th Jun 20162:27 pmRNSDirector/PDMR Shareholding
9th Jun 20168:00 amRNSKainos appoints new Commercial Client Director
31st May 20167:00 amRNSPreliminary Results
3rd May 20167:00 amRNSNotice of Results
19th Apr 20167:00 amRNSCapital Markets Day
31st Mar 20164:11 pmRNSDirector/PDMR Shareholding
16th Mar 20167:01 amRNSKainos Evolve and InTouch Health Partnership
16th Mar 20167:00 amRNSTrading Update
8th Mar 20161:38 pmRNSDirector/PDMR Shareholding
1st Mar 201610:00 amRNSDirector/PDMR Shareholding
11th Feb 20166:09 pmRNSDirector/PDMR Shareholding
1st Feb 20167:00 amRNSInvestment in Cirdan Imaging Limited
27th Jan 201611:32 amRNSDirector/PDMR Shareholding
29th Dec 20152:59 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSTransfer of Shares
21st Dec 201510:00 amRNSDisposal of investment in SpeechStorm Limited
18th Dec 20152:42 pmRNSDirector/PDMR Shareholding
17th Dec 20154:46 pmRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim Results
30th Sep 201512:27 pmRNSDirector/PDMR Shareholding
15th Sep 20155:54 pmRNSDirector/PDMR Shareholding
9th Sep 20155:27 pmRNSDirector/PDMR Shareholding
7th Sep 20159:00 amRNSNotice of Results
25th Aug 20158:00 amRNSNew Mobile-Enabled healthcare platform
24th Aug 20155:31 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSHolding(s) in Company
16th Jul 20159:05 amRNSDirector/PDMR Shareholding
10th Jul 20157:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.